Michael Ott

Michael Ott

Michael Ott is an Associate Professor at Umeå University, affiliated with the Department of Public Health and Clinical Medicine and a senior consultant in internal medicine and nephrology at the university hospital of Umeå and the psychiatric clinic in Sunderby, Luleå.  

Michael´s doctoral thesis was based on assessing the physiology of the epithelial sodium channel, ENaC. His later academic work is situated at the intersection of psychiatry, nephrology, and internal medicine, with a particular focus on the long-term effects of lithium treatment in patients with bipolar and schizoaffective disorders. He is a key contributor to the LiSIE (Lithium – Study into Effects and Side Effects) retrospective cohort study, which examines the long-term outcomes of lithium use in Northern Sweden. This work has provided valuable insights into lithium-induced renal dysfunction, thyroid abnormalities, lithium intoxication and the risk-benefit balance of lithium as a mood stabilizer. 

Michael is treating patients with special interest on lithium induced nephropathy since 2010. This includes patients on lithium with polydipsia-polyuria syndrome, chronic kidney disease before and on dialysis, and after kidney transplantation.